ReGen Therapeutics Regenerating?

      Regen Therapeutics plc reported various new shareholders had taken stakes in the company, which is in the process of splitting its shares into more shares (after earlier doing a reverse split.) Because of this I will report on the basis of percentages rather than the number of shares which is about 13 million total outstand pre 2:1 split.

  REGUF reported that 4% of its stock has beena cquired by Headstart Global Fund and another 4% by Headstart Global Aggressive Fund. I have no idea who these are. Barclays, the British bank, has now pushed its shareholding in ReGen to over 5%. And the existing supporters, Mr. Andrew Clement Wilson of Belfast, with 15% of the total out, and two entities controlled by Tigran Kalaydjan, with 3.54%, continue to own that proportion of shares post-split. So just under a third of the stock of this British developer of nutraceuticals like Colostrinin (now being launched in Cyprus and Australia) and an old drug which may help some seemingly brain-dead patients, is closely held by big boys.

   I am not sure if the BARC stake is for investment or for some British rule related to the ReGen's London listing. It also has a very illiquid ADR.